Business
iMDx Welcomes New VP Marketing to Prepare for Commercial Transplant Assay Launch
Steven Tahmooressi to lead global marketing efforts for GraftAssure family of assays and future productsBrings 25 years of experience driving new product adoption across geographies in transplantation, oncology and immunology NASHVILLE, Tenn., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., (Nasdaq: IMDX), (iMDx), today announced that it has welcomed Steven Tahmooressi to its executive leadership team as the company prepares to launch its first clinical kitted assay in 2026
About this update from Astellas Pharma Inc.
[{"type":"image","alt":"Insight Molecular Diagnostics Inc.","displaySize":"","headline":null,"caption":"Insight Molecular Diagnostics Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":114,"url":"https://media.zenfs.com/en/globenewswire.com/0d7abfd3cc0e9f19d3f8615dce794ac4"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/a9omE9cBUejfoy9a_jJadQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE2MDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/0d7abfd3cc0e9f19d3f8615dce794ac4","width":300,"height":114}},"lazy":false},{"type":"image","alt":"VP Marketing Tahmooressi","displaySize":"","headline":null,"caption":"VP Marketing Tahmooressi","className":"","disableSlideshowImg":false,"size":{"original":{"width":440,"height":440,"url":"https://media.zenfs.com/en/globenewswire.com/b9c8b74eea0f6e0a764cadc8635783f2"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/SeeLoWq5jjfDpguDR1E8fA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTcwNTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/b9c8b74eea0f6e0a764cadc8635783f2","width":440,"height":440}}},{"type":"text","content":"","length":0,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Steven Tahmooressi to lead global marketing efforts for GraftAssure family of assays and future products","length":104,"tagName":"p"}]},{"val":[{"type":"text","content":"Brings 25 years of experience driving new product adoption across geographies in transplantation, oncology and immunology","length":121,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":225,"olType":false},{"type":"text","content":"NASHVILLE, Tenn., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., (Nasdaq: IMDX), (iMDx), today announced that it has welcomed Steven Tahmooressi to its executive leadership team as the company prepares to launch its first clinical kitted assay in 2026.","length":275,"tagName":"p"},{"type":"text","content":"As Vice President of Marketing, Mr. Tahmooressi will be responsible for leading transplant and oncology assay marketing, bringing more than 25 years of healthcare industry experience, including a strong history in supporting the transplantation community, ranging from U.S. sales and marketing leadership to regional and global commercialization.","length":346,"tagName":"p"},{"type":"text","content":"Mr. Tahmooressi joins iMDx most recently from Aste...